Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies
- 1 December 2007
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 370 (9605) , 2118-2125
- https://doi.org/10.1016/s0140-6736(07)61906-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbationsInternational Journal Of Clinical Practice, 2007
- Sequence, Haplotype, and Association Analysis ofADRβ2in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthmaJournal of Allergy and Clinical Immunology, 2006
- A Note on Exact Tests of Hardy-Weinberg EquilibriumAmerican Journal of Human Genetics, 2005
- Meta-analysis of the association of β2-adrenergic receptor polymorphisms with asthma phenotypesJournal of Allergy and Clinical Immunology, 2005
- Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trialPublished by Elsevier ,2004
- Detection of genotyping errors by Hardy–Weinberg equilibrium testingEuropean Journal of Human Genetics, 2004
- Asthma variability in patients previously treated with β2-agonists aloneJournal of Allergy and Clinical Immunology, 2003
- Asthma exacerbations during long term beta agonist use: influence of beta 2 adrenoceptor polymorphismThorax, 2000
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997